SkinHealth Systems Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $300.8M | $334.3M | $398.0M | $365.9M | $260.1M |
| Gross profit | $196.4M | $182.3M | $155.1M | $248.8M | $178.5M |
| Operating income | -$20.8M | -$67.8M | -$130.9M | -$25.8M | -$39.9M |
| Operating expenses | $217.2M | $250.1M | $286.0M | $274.6M | $218.5M |
| Cost of revenue | $104.4M | $152.0M | $242.9M | $117.1M | $81.5M |
| Cash from operations | $37.5M | $16.1M | $21.8M | -$106.6M | -$28.4M |
| Capital expenditure | $303,000 | $756,000 | $3.8M | $10.8M | $11.2M |
| Free cash flow | $37.2M | $15.4M | $17.9M | -$117.4M | -$39.6M |
| Share repurchases | $0 | $0 | $30.2M | $160.0M | $0 |
| Total assets | $499.8M | $685.7M | $929.1M | $1.0B | $1.2B |
| Total liabilities | $438.7M | $633.9M | $869.7M | $836.0M | $916.5M |
Shares outstanding 129.6M · Free float 31.8%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.